Iradimed Q1 record revenue $19.5M (+11% YoY); EPS $0.37 GAAP, $0.42 non-GAAP

IRADIMED CORP

2025-Q1 EPS reported $0.37 revenue$19,510,637

Record Q1 revenue of $19.5M, up 11% YoY from $17.6M; GAAP diluted EPS $0.37 (+16% YoY).
Non-GAAP diluted EPS $0.42 (+17% YoY); excludes $0.7M stock compensation net of tax.
Declared regular quarterly cash dividend of $0.17/share, payable May 30, 2025 to holders of record May 20.
Q2 2025 guidance: revenue $19.7-19.9M; GAAP EPS $0.37-0.40; non-GAAP EPS $0.41-0.44.
Reaffirms FY 2025 guidance: revenue $78-82M; GAAP EPS $1.55-1.65; non-GAAP EPS $1.71-1.81.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.